Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-16-021029)

Filing Details

Accession Number:: 0001179110-16-021029
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-03-04 16:14:38
Reporting Period:: 2016-03-04

Filing Date:: 2016-03-04
Accepted Time:: 2016-03-04 16:14:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
896264	Usana Health Sciences Inc	USNA	Medicinal Chemicals & Botanical Products (2833)	870500306

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1203304	G Jerry Mcclain	3838 West Parkway Blvd Salt Lake City UT 84120		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-03-04	767	$57.62	767	No	4	M	Direct
Common Stock	Disposition	2016-03-04	767	$118.17	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock-Settled Stock Appreciation Rights	Disposition	2016-03-04	1,500	$0.00	1,500	$57.62

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,500	2016-01-01	2018-06-15	No	4	M	Direct

Footnotes

The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II.
Weighted average price. Price range in multiple transactions was $118.00 to $118.50, inclusive.